Ani Rare Disease Patient Assistance Program Inc
Accepts applications
Ani Rare Disease Patient Assistance Program Inc is a private foundation in Baudette, Minnesota. In tax year 2024 it gave $162 million in 1 grant; the typical grant was $162 million and the largest $162 million. It accepts applications; its filing gives the instructions below.
From its IRS Form 990-PF for tax year 2024.
- Grants paid, 2024$162 million
- Number of grants1
- Typical grant$162 million
- Largest grant$162 million
- Assets$5.8 million
- New grantees0%
Giving in 2024 was up from $76.9 million the year before.
0% of its 2024 grantees had not received a grant from it the year before, so most of its money goes to organizations it already funds.
Giving by year
| Tax year | Grants paid | Number of grants | Assets |
|---|---|---|---|
| 2023 | $76.9 million | 1 | $687,602 |
| 2024 | $162 million | 1 | $5.8 million |
How to apply
This is a patient assistance program. Its grants are medicine given free to patients, so it does not fund organizations.
| Contact | Ani Rare Disease Patient Assistance 210 Main Street West, Baudette, MN 56623 |
|---|---|
| Phone or email | (312) 853-1131 |
| What to submit | PATIENTS WILL BE REQUIRED TO SUBMIT AN APPROPRIATE APPLICATION TO THE FOUNDATION TO DETERMINE THE PATIENT'S ELIGIBILITY TO PARTICIPATE IN THE PROGRAM. THE PROGRAM WILL COLLECT APPROPRIATE DOCUMENTATION FROM EACH PATIENT APPLICANT SUFFICIENT TO ESTABLISH THAT PATIENT'S SATISFACTION OF THE LIMITED, TAILORED ELIGIBILITY STANDARDS DISCUSSED ABOVE AND AS IMPLEMENTED BY THE FOUNDATION'S BOARD OF DIRECTORS FROM TIME TO TIME. Application is available at the following: https://www.cortrophin.com/pdfs/purified-cortrophin-gel-patient-assist ance-application.pdf |
| Deadlines | Program eligibility will be determined on an annual basis and patients who wish to re-enroll in the |
| Restrictions | The organization plans to distribute a pharmaceutical product donated by ANI Pharmaceuticals, Inc. from its Rare Disease portfolio to eligible patients suffering from covered rare diseases.Patients must permanently reside in the U.S. or a U.S. territory, have a valid prescription for an FDA-approved use of the product, and must either lack health insurance coverage for the product or, to the extent the patient has health insurance, demonstrate that the relevant plan does not adequately cover the costs of the product, based on standards established by the organization's board of directors. Applicants must submit an annual application to demonstrate they meet the applicable eligibility criteria |
What Ani Rare Disease Patient Assistance Program Inc funds
Where it gives
All of its grants went to recipients in Minnesota.
| State | Grants | Amount |
|---|---|---|
| Minnesota | 1 | $162 million |
Grants paid in 2024
| Recipient | Purpose | Amount |
|---|---|---|
| Donations US | Serve Patients and improving lives | $162 million |
Officers and trustees
- Stephen Carey
- Meredith Cook
- Mary Pao
- Elizabeth Powell
Questions people ask
Does Ani Rare Disease Patient Assistance Program Inc accept grant applications?
Yes. Its latest IRS filing says it accepts applications, with this on deadlines: Program eligibility will be determined on an annual basis and patients who wish to re-enroll in the.
How much does Ani Rare Disease Patient Assistance Program Inc give?
$162 million in tax year 2024, across 1 grant, with a typical grant of $162 million.
Who runs Ani Rare Disease Patient Assistance Program Inc?
Its 2024 filing lists Stephen Carey (Director, Treasurer), Meredith Cook (Director), Mary Pao (Director, President) and Elizabeth Powell (Secretary).
What does Ani Rare Disease Patient Assistance Program Inc fund?
Based on its grants, mainly health.